Results
Concord Biotech Q1 FY27 Revenue Up 26% YoY
Concord Biotech reported Q1 FY27 revenue of ₹257 crore, a 26% YoY growth, driven by broad-based demand and export growth of 46%.
EBITDA grew 34% to ₹82 crore with margins at 32%, while the company rem
